Loomis, Sayles & Company
BHC icon

Loomis, Sayles & Company’s Bausch Health BHC Stock Holding History

Loomis, Sayles & Company’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-494
Closed -$4K – 955
2022
Q2 		$4K Hold
494
– – ﹤0.01% 738
2022
Q1 		$11K Buy
+494
New +$12.1K ﹤0.01% 702
2015
Q4 		– Sell
-452,692
Closed -$80.8M – 1049
2015
Q3 		$80.8M Sell
452,692
-90,523
-17% -$21.1M 0.24% 64
2015
Q2 		$121M Sell
543,215
-1,014
-0.2% -$225K 0.33% 57
2015
Q1 		$108M Buy
544,229
+38,715
+8% +$6.87M 0.3% 64
2014
Q4 		$72.3M Sell
505,514
-1,158,645
-70% -$156M 0.2% 100
2014
Q3 		$218M Buy
1,664,159
+312,900
+23% +$37.3M 0.64% 36
2014
Q2 		$170M Sell
1,351,259
-1,900,226
-58% -$242M 0.48% 43
2014
Q1 		$429M Sell
3,251,485
-1,439,672
-31% -$197M 1.21% 11
2013
Q4 		$551M Sell
4,691,157
-2,803
-0.1% -$307K 1.65% 8
2013
Q3 		$490M Hold
4,693,960
– – 1.59% 8
2013
Q2 		$404K Buy
+4,693,960
New +$370M 1.44% 10

Other funds holding BHC

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

Loomis, Sayles & Company's BHC Position: Q3 2022 in Review

Loomis, Sayles & Company sold out of Bausch Health (BHC) in Q3 2022, closing a stake of 494 shares — an estimated $4K sold.

Loomis, Sayles & Company first reported a position in BHC in Q2 2013 and held it in 12 quarters. The position peaked at $551M in Q4 2013. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.

  • Loomis, Sayles & Company reported no remaining Bausch Health position as of Q3 2022 after selling out during the quarter.
  • Loomis, Sayles & Company sold 494 Bausch Health shares in Q3 2022, an estimated $4K.
  • Loomis, Sayles & Company first reported a position in Bausch Health in Q2 2013 and held it in 12 quarters.
  • Loomis, Sayles & Company's Bausch Health position peaked at $551M in Q4 2013.
  • 283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.

Based on Loomis, Sayles & Company's 13F filing for Q3 2022, filed 14 Nov 2022.